Some 30 million of the 33 million people worldwide infected with human immunodeficiency virus are in low- and middle-income nations, and two-thirds are in sub-Saharan Africa.
Gilead Sciences Inc., the Foster City-based biopharmaceutical company that manufactures several of the world's key drugs for fighting HIV infection, is thus fundamentally global. When the company gained U.S. Food and Drug Administration approval for its HIV drug Viread in 2001, it did so ami... (continued)